Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 5 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| MYRIAD GENETICS INC | 106,802 | reported | 02 Jun 2022 | tx 118+576,802−490,000 |
| Ernexa Therapeutics Inc. | 67,000 | reported | 08 Dec 2021 | tx 1+67,000 |
| DELCATH SYSTEMS, INC. | 30,000 | reported | 10 Jun 2015 | tx 3+80,000 |
| Dicerna Pharmaceuticals Inc | 25,000 | reported | 20 Jun 2019 | tx 30+513,997−381,104 |
| GOLF TRUST OF AMERICA INC | 25,000 | reported | 22 May 2018 | tx 3+79,000 |
| Quoin Pharmaceuticals, Ltd. | 21,709 | reported | 04 Feb 2026 | tx 11+177,277−297 |
| Myriad Pharmaceuticals, Inc. | 16,250 | reported | 08 Dec 2011 | tx 3+57,500 |
| PHARMACOPEIA DRUG DISCOVERY INC | 15,000 | reported | 30 Apr 2008 | tx 1+15,000 |
| TRANSKARYOTIC THERAPIES INC | 10,000 | reported | 22 Jun 2004 | tx 2+20,000 |
| AUXILIUM PHARMACEUTICALS INC | 5,000 | reported | 03 Jun 2010 | tx 13+51,496 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 Feb 2026 | GRANT_AWARD | Quoin Pharmaceuticals, Ltd. | 21,709 | 0.00 USD | deriv |
| 14 Oct 2025 | PURCHASE | Quoin Pharmaceuticals, Ltd. | 15,152 | 8.49 USD | |
| 14 Oct 2025 | PURCHASE | Quoin Pharmaceuticals, Ltd. | 15,152 | — | deriv |
| 14 Oct 2025 | PURCHASE | Quoin Pharmaceuticals, Ltd. | 15,152 | — | deriv |
| 14 Oct 2025 | PURCHASE | Quoin Pharmaceuticals, Ltd. | 15,152 | — | deriv |
| 14 Oct 2025 | PURCHASE | Quoin Pharmaceuticals, Ltd. | 15,152 | — | deriv |
| 21 Aug 2025 | GRANT_AWARD | Quoin Pharmaceuticals, Ltd. | 13,682 | 0.00 USD | deriv |
| 29 May 2025 | GRANT_AWARD | Quoin Pharmaceuticals, Ltd. | 7,760 | 0.00 USD | deriv |
| 09 Dec 2024 | GRANT_AWARD | Quoin Pharmaceuticals, Ltd. | 50,714 | 0.00 USD | deriv |
| 07 Jun 2024 | SALE | Quoin Pharmaceuticals, Ltd. | 297 | 0.73 USD | anomaly |
| 26 Oct 2023 | GRANT_AWARD | Quoin Pharmaceuticals, Ltd. | 7,652 | 0.00 USD | deriv |
| 02 Jun 2022 | GRANT_AWARD | MYRIAD GENETICS INC | 17,275 | 0.00 USD | |
| 08 Dec 2021 | GRANT_AWARD | Ernexa Therapeutics Inc. | 67,000 | 0.00 USD | deriv |
| 03 Aug 2021 | SALE | MYRIAD GENETICS INC | 30,000 | 34.75 USD | |
| 03 Aug 2021 | EXERCISE | MYRIAD GENETICS INC | 30,000 | 25.39 USD | |
| 03 Aug 2021 | EXERCISE | MYRIAD GENETICS INC | 30,000 | 0.00 USD | deriv |
| 03 Jun 2021 | GRANT_AWARD | MYRIAD GENETICS INC | 12,848 | 0.00 USD | |
| 04 Dec 2020 | GRANT_AWARD | MYRIAD GENETICS INC | 15,889 | 0.00 USD | |
| 05 Dec 2019 | GRANT_AWARD | MYRIAD GENETICS INC | 11,687 | 0.00 USD | |
| 20 Jun 2019 | GRANT_AWARD | Dicerna Pharmaceuticals Inc | 25,000 | 0.00 USD | deriv |
| 29 Nov 2018 | GRANT_AWARD | MYRIAD GENETICS INC | 9,360 | 0.00 USD | |
| 15 Aug 2018 | SALE | Dicerna Pharmaceuticals Inc | 23,810 | 16.00 USD | |
| 15 Aug 2018 | SALE | Dicerna Pharmaceuticals Inc | 14,531 | 16.00 USD | |
| 21 Jun 2018 | GRANT_AWARD | Dicerna Pharmaceuticals Inc | 25,000 | 0.00 USD | deriv |
| 08 Jun 2018 | EXERCISE | MYRIAD GENETICS INC | 13,664 | 21.29 USD |